Bicara Therapeutics Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BCAX Nasdaq 2834 www.bicara.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bicara Therapeutics Inc.

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET - Aug 4th, 2026 6:30 am
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors - Jul 28th, 2026 6:30 am
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2026 6:30 am
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors? - Jun 12th, 2026 11:21 pm
Bicara (BCAX) Q4 2025 Earnings Transcript - Jun 1st, 2026 10:13 am
Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer - May 22nd, 2026 9:09 am
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC - May 21st, 2026 3:00 pm
A Look At Bicara Therapeutics (BCAX) Valuation After Recent Share Price Pullback - May 19th, 2026 7:09 am
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet - May 15th, 2026 5:02 pm
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back - May 15th, 2026 4:56 pm
Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data - May 14th, 2026 3:09 pm
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - May 13th, 2026 6:30 am
Bicara Therapeutics Inc (BCAX) Q1 2026 Earnings Call Highlights: Strategic Advances and ... - May 12th, 2026 1:03 am
Bicara Therapeutics Inc. Common Stock Q1 2026 Earnings Call Summary - May 11th, 2026 2:51 pm
Bicara Therapeutics Q1 Earnings Call Highlights - May 11th, 2026 8:07 am
Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - May 11th, 2026 5:30 am
Bicara Therapeutics Chief Medical Officer Sells 5,500 Shares for $126,000 - May 4th, 2026 8:04 am
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET - May 4th, 2026 6:30 am
A Look At Bicara Therapeutics (BCAX) Valuation After Earnings Losses And New Shelf Registration - Apr 6th, 2026 6:18 pm
Wall Street Analysts Believe Bicara Therapeutics Inc. (BCAX) Could Rally 54.85%: Here's is How to Trade - Apr 1st, 2026 7:55 am